BS
DXCM icon

Boenning & Scattergood’s DexCom DXCM Stock Holding History

Boenning & Scattergood’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$240K Buy
+470
New +$51.6K 0.04% 352
2022
Q2 		– Sell
-1,880
Closed -$240K – 383
2022
Q1 		$240K Hold
1,880
– – 0.04% 352
2021
Q4 		$252K Hold
1,880
– – 0.04% 340
2021
Q3 		$257K Hold
1,880
– – 0.05% 328
2021
Q2 		$201K Buy
+1,880
New +$181K 0.04% 361

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boenning & Scattergood's DXCM Position: Q4 2022 in Review

Boenning & Scattergood opened a new position in DexCom (DXCM) in Q4 2022: 470 shares worth $240K. The stake represents 0.04% of the portfolio and ranks #352 among its holdings. This is a return to the name: Boenning & Scattergood previously reported a position in DXCM as recently as Q1 2022.

Boenning & Scattergood first reported a position in DXCM in Q2 2021 and has held it in 5 quarters since. The position peaked at $257K in Q3 2021. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

  • Boenning & Scattergood held 470 shares of DexCom worth $240K as of Q4 2022.
  • DexCom was a new Boenning & Scattergood position in Q4 2022.
  • DexCom made up 0.04% of Boenning & Scattergood's portfolio in Q4 2022, its #352 holding.
  • Boenning & Scattergood first reported a position in DexCom in Q2 2021 and has held it in 5 quarters since.
  • Boenning & Scattergood's DexCom position peaked at $257K in Q3 2021.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.